CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing Patient Outcomes and Economic Burden of CRBSI

NEXT STORY
Charcot-Marie-Tooth Disease Market to Surpass US$ 3,459.1 Million by 2028, Says Coherent Market Insights (CMI)
PREV STORY
Kirkland Lake Gold Announces Filing of Amended and Restated Detour Lake Mine Technical Report
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB (publ) (”Oasmia” or ”Company” or “Group”) on 18 April 2018 issued ...

author_avatar
NASDAQ Market News

Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Will Reach USD 547.60 Million by 2022: Zion Market Research

Sarasota, FL, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a ...

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Completion of Enrollment for Confirmatory Phase III Study with TALICIA® for H. pylori Infection

Top-line results from the randomized, double-blind confirmatory Phase III study (ERADICATE Hp2 study) with ...

author_avatar
NASDAQ Market News